Gefitinib API

Name	Gefitinib
Chinese name	吉非替尼
Cas Number	184475-35-2
Source	India
Qualifications	USDMF/CEP/-/-/-

Gefitinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), which blocks conduction by inhibiting EGFR autophosphorylation, inhibits tumor cell growth, metastasis and angiogenesis, and achieves targeting Treatment, and has good tolerance. Tinib targeted drugs are an important group of anti-tumor clinical drugs, with many advantages such as broad anti-cancer spectrum, high targeting, significant curative effect, and small adverse reactions. In 2005, the world's first lung cancer oral targeted drug gefitinib was approved to enter China, bringing hope to patients with non-small cell lung cancer with EGFR-positive mutations, and also ushering in the era of precision lung cancer treatment in China.

Hot Tags: gefitinib api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Rasagiline Mesylate API, Celecoxib API, Ulipristal Acetate API, Active Pharmaceutical Ingredient, Bemeprost API, Clofarabine API

• Previous: Pramipexole Chloride API
• Next: Olopatadine Hydrochloride API